Further to our Early Notification and Brand Change article of 29 March 2019 advising of a future brand change.

We are pleased in association with Apotex to be able to make a significant offer to encourage your continued use of Montelukast-Apo Tab 4 mg & 10 mg 28’s until supplies are exhausted or 31 December 2019, whichever comes first.

Stock is sold on a Non-Returnable basis. (We purchase on the same basis)

Margin is a critical part of your business and any additional margin provided with minimal risk is truly advantageous.

Click here to access the analysis which clearly demonstrates the benefit of continuing to purchase and dispense the incumbent brand in the 4 mg and 10 mg strengths. Deal commences 16 June 2019.

Please note 5 mg is excluded as stock will be exhausted well before the implementation of change in Sole Supply brand 1 January 2020.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author